Form 8-K - Current report:
SEC Accession No. 0001104659-23-067829
Filing Date
2023-06-05
Accepted
2023-06-05 07:05:23
Documents
14
Period of Report
2023-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2317771d1_8k.htm   iXBRL 8-K 27079
2 EXHIBIT 99.1 tm2317771d1_ex99-1.htm EX-99.1 25186
6 GRAPHIC tm2317771d1_ex99-1img001.jpg GRAPHIC 3499
  Complete submission text file 0001104659-23-067829.txt   236912

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20230605.xsd EX-101.SCH 3085
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20230605_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20230605_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2317771d1_8k_htm.xml XML 3477
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 23991208
SIC: 2834 Pharmaceutical Preparations